These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 8850370

  • 1. Radiosensitizing effect of nicotinamide and carbogen combined in fractionated pions or x-rays in SCCVII tumors.
    Ohizumi Y, Lam GK, Pickles T, Fryer C, Chaplin DJ.
    Radiat Med; 1995; 13(6):291-5. PubMed ID: 8850370
    [Abstract] [Full Text] [Related]

  • 2. Early skin response to fractionated doses of pions for determining therapeutic gain factors.
    Ohizumi Y, Lam GK, Pickles T, Chaplin DJ.
    Tokai J Exp Clin Med; 1996 Jun; 21(2):69-75. PubMed ID: 9239808
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
    el-Said A, Menke D, Dorie MJ, Brown JM.
    Radiat Oncol Investig; 1999 Jun; 7(3):163-9. PubMed ID: 10406058
    [Abstract] [Full Text] [Related]

  • 4. Radiosensitization of SCCVII tumours and normal tissues by nicotinamide and carbogen: analysis by micronucleus assay.
    Ono K, Masunaga S, Akuta K, Akaboshi M, Abe M.
    Radiother Oncol; 1993 Aug; 28(2):162-7. PubMed ID: 8248558
    [Abstract] [Full Text] [Related]

  • 5. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
    Horsman MR, Overgaard J.
    Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
    [Abstract] [Full Text] [Related]

  • 6. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
    Chaplin DJ, Horsman MR, Siemann DW.
    Br J Cancer; 1993 Aug; 68(2):269-73. PubMed ID: 8347481
    [Abstract] [Full Text] [Related]

  • 7. The effects of nicotinamide plus carbogen or pions for microscopic SCCVII tumors.
    Nishioka A, Ohizumi Y, Lam GK, Pickles TA, Chaplin DJ, Ogawa Y, Inomata T, Yoshida S.
    Oncol Rep; 1999 Aug; 6(3):583-6. PubMed ID: 10203595
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
    Dorie MJ, Menke D, Brown JM.
    Int J Radiat Oncol Biol Phys; 1994 Jan 01; 28(1):145-50. PubMed ID: 8270435
    [Abstract] [Full Text] [Related]

  • 9. Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules.
    Rojas A, Vojnovic B, Johns H, Joiner MC, Martindale C, Fowler JF, Denekamp J.
    Radiother Oncol; 1996 Apr 01; 39(1):53-64. PubMed ID: 8735494
    [Abstract] [Full Text] [Related]

  • 10. Radiosensitization of murine tumors by Fluosol-DA 20%.
    Lee I, Levitt SH, Song CW.
    Radiat Res; 1990 Jun 01; 122(3):275-9. PubMed ID: 2113298
    [Abstract] [Full Text] [Related]

  • 11. Hyperbaric oxygen improves tumor radiation response significantly more than carbogen/nicotinamide.
    Brizel DM, Hage WD, Dodge RK, Munley MT, Piantadosi CA, Dewhirst MW.
    Radiat Res; 1997 Jun 01; 147(6):715-20. PubMed ID: 9189170
    [Abstract] [Full Text] [Related]

  • 12. [Radiosensitization of Lewis lung tumor by perfluorochemical emulsion comparison between single and fractionated irradiation].
    Hishikawa-itoh Y, Miyata N.
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr 20; 25(4):781-7. PubMed ID: 2142500
    [Abstract] [Full Text] [Related]

  • 13. Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide.
    Hoskin PJ, Saunders MI, Dische S.
    Cancer; 1999 Oct 01; 86(7):1322-8. PubMed ID: 10506720
    [Abstract] [Full Text] [Related]

  • 14. Biological effectiveness of fractionated dose of pions in microscopic SCCVII tumors: comparison between tumor control dose and tumor growth time assays.
    Ohizumi Y, Lam GK, Pickles T, Chaplin DJ.
    Jpn J Cancer Res; 1995 Jun 01; 86(6):600-6. PubMed ID: 7622425
    [Abstract] [Full Text] [Related]

  • 15. Nicotinamide as a repair inhibitor in vivo: studies using single and fractionated X-ray doses in mouse skin and kidneys.
    Rojas A, Denekamp J, Johns H, Kjellen E, Tsang R, Nilsson P, Stratford MR, Dennis MF, Joiner MC.
    Radiat Res; 1996 Apr 01; 145(4):419-31. PubMed ID: 8600502
    [Abstract] [Full Text] [Related]

  • 16. Oxygen-modifying treatment with ARCON reduces the prognostic significance of hemoglobin in squamous cell carcinoma of the head and neck.
    Hoogsteen IJ, Pop LA, Marres HA, Merkx MA, van den Hoogen FJ, van der Kogel AJ, Kaanders JH.
    Int J Radiat Oncol Biol Phys; 2006 Jan 01; 64(1):83-9. PubMed ID: 16213107
    [Abstract] [Full Text] [Related]

  • 17. Reduction of tumor hypoxia and inhibition of DNA repair by nicotinamide after irradiation of SCCVII murine tumors and normal tissues.
    Zheng H, Olive PL.
    Cancer Res; 1996 Jun 15; 56(12):2801-8. PubMed ID: 8665517
    [Abstract] [Full Text] [Related]

  • 18. The radiation response of KHT sarcomas following nicotinamide treatment and carbogen breathing.
    Siemann DW, Horsman MR, Chaplin DJ.
    Radiother Oncol; 1994 May 15; 31(2):117-22. PubMed ID: 8066190
    [Abstract] [Full Text] [Related]

  • 19. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
    Murata R, Tsujitani M, Horsman MR.
    Radiother Oncol; 2008 Jun 15; 87(3):331-8. PubMed ID: 18375007
    [Abstract] [Full Text] [Related]

  • 20. The effect of combined nicotinamide and carbogen treatments in human tumour xenografts: oxygenation and tumour control studies.
    Stüben G, Stuschke M, Knühmann K, Horsman MR, Sack H.
    Radiother Oncol; 1998 Aug 15; 48(2):143-8. PubMed ID: 9783885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.